Compounded with
Semaglutide
First-party site lists commercial Wegovy semaglutide by Novo Nordisk.
Tirzepatide
First-party site lists commercial Zepbound tirzepatide by Eli Lilly.
Product evidence does not establish current availability.
Pharmacy evidence record · researched 2026-08-20
Wells Pharmacy Network LLC
First-party site lists commercial Wegovy semaglutide by Novo Nordisk.
First-party site lists commercial Zepbound tirzepatide by Eli Lilly.
Product evidence does not establish current availability.
Regulatory compliance
A pathway label describes which federal rules apply — it is not a quality claim.
Section 503A
verified first party
Section 503B
FDA's compounding-action index labels the Dyersburg location a 503B facility and the first-party site calls it FDA-registered. An exact row from the current weekly registry was not recovered, so the most-recent registration date is unverified.
Telehealth providers
Clinic Scout links a provider only when an explicit source names the relationship.
Regulatory history
FDA compounding-action, Form 483, warning/untitled-letter, and current-503B sources were checked. The 2025 untitled letter and multiple Dyersburg inspection records were found; state-board action searches were not completed.
U.S. Food and Drug Administration · 2025-10-14
Following an April 14-25, 2025 inspection, FDA stated that products failed to meet section 503B conditions and described production-practice deficiencies.
Status not statedNo Clinic Scout patient reviews are published for this pharmacy. Submissions go through manual moderation before anything appears here.
What this record verifies for you
Each line traces to a citation in the source list below — read the exact captured wording before relying on it.
No superiority claim is made for review volume, ratings, or patient sentiment.
Wells Pharmacy Network operates a 503A compounding pharmacy in Ocala, Florida as well as an FDA Registered 503B Outsourcing Facility in Dyersburg, Tennessee.
Wells Pharmacy Network LLC, Dyersburg, TN- 503B Facility
From April 14, 2025, to April 25, 2025, FDA investigators inspected your facility, Wells Pharmacy Network, LLC, located at 450 US Highway 51 BYP N, Dyersburg, TN 38024.
Semaglutide (Wegovy®) Injectable (Commercial Product by Novo Nordisk)
Tirzepatide (Zepbound®) Injection (Commercial Product by Eli Lilly Company)
GLP Clinic Scout does not issue a blanket legitimacy verdict. This research record preserves 5 dated first-party or regulator citation(s), 1 regulatory/action record(s), and 6 explicitly unresolved field(s). Review the cited evidence and current license status before making a decision.
Weekly price watch
One useful comparison each week. No spam, no sold lists, and you can unsubscribe anytime.